A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers
León-Cachón, Rafael B. R., Ascacio-Martínez, Jorge A., Gamino-Peña, María E., Cerda-Flores, Ricardo M., Meester, Irene, Gallardo-Blanco, Hugo L., Gómez-Silva, Magdalena, Piñeyro-Garza, Everardo, BarreVolume:
16
Langue:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-016-2062-2
Date:
December, 2016
Fichier:
PDF, 1.02 MB
english, 2016